Hubro Therapeutics

Developer of immunotherapies for cancer treatment

placeOslo, Oslo, Norway calendar_todayFounded 2018 groups5 employees language hubrotherapeutics.com

Registered entities

Investor mix

3 investors on record; lead investors include Investinor.

Investor typeCountShare
Venture capital3100%
Coming soon